AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
EVIDENCE FOR THE DURATION OF THE ANTIFOLATE ACTION OF THE THYMIDYLATESYNTHASE (TS) INHIBITOR ZD9331 USING PLASMA DURD AS A SURROGATE MARKER OF ENZYME-INHIBITION
Authors: JACKMAN AL MITCHELL F LYNN S AHERNE GW REES C CALVERT AH JUDSON IR DIAB S MAYNE K SMITH M
Citation: Al. Jackman et al., EVIDENCE FOR THE DURATION OF THE ANTIFOLATE ACTION OF THE THYMIDYLATESYNTHASE (TS) INHIBITOR ZD9331 USING PLASMA DURD AS A SURROGATE MARKER OF ENZYME-INHIBITION, Annals of oncology, 9, 1998, pp. 604-604
CARBOGEN BREATHING INCREASES 5-FLUOROURACIL UPTAKE AND CYTOTOXICITY IN HYPOXIC MURINE RIF-1 TUMORS - A MAGNETIC-RESONANCE STUDY IN-VIVO
Authors: MCSHEEHY PMJ ROBINSON SP OJUGO ASE ABOAGYE EO CANNELL MB LEACH MO JUDSON IR GRIFFITHS JR
Citation: Pmj. Mcsheehy et al., CARBOGEN BREATHING INCREASES 5-FLUOROURACIL UPTAKE AND CYTOTOXICITY IN HYPOXIC MURINE RIF-1 TUMORS - A MAGNETIC-RESONANCE STUDY IN-VIVO, Cancer research, 58(6), 1998, pp. 1185-1194
INFLUENCE OF PH ON THE UPTAKE OF 5-FLUOROURACIL INTO ISOLATED TUMOR-CELLS
Authors: OJUGO ASE MCSHEEHY PMJ STUBBS M ALDER G BASHFORD CL MAXWELL RJ LEACH MO JUDSON IR GRIFFITHS JR
Citation: Ase. Ojugo et al., INFLUENCE OF PH ON THE UPTAKE OF 5-FLUOROURACIL INTO ISOLATED TUMOR-CELLS, British Journal of Cancer, 77(6), 1998, pp. 873-879
A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY IN-VIVO OF HUMAN HT29 TUMORS USING F-19 AND P-31 MAGNETIC-RESONANCE SPECTROSCOPY
Authors: MCSHEEHY PMJ SEYMOUR MT OJUGO ASE RODRIGUES LM LEACH MO JUDSON IR GRIFFITHS JR
Citation: Pmj. Mcsheehy et al., A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY IN-VIVO OF HUMAN HT29 TUMORS USING F-19 AND P-31 MAGNETIC-RESONANCE SPECTROSCOPY, European journal of cancer, 33(14), 1997, pp. 2418-2427
TOMUDEX (RALTITREXED) DEVELOPMENT - PRECLINICAL, PHASE-I AND PHASE-IISTUDIES
Authors: JUDSON IR
Citation: Ir. Judson, TOMUDEX (RALTITREXED) DEVELOPMENT - PRECLINICAL, PHASE-I AND PHASE-IISTUDIES, Anti-cancer drugs, 8, 1997, pp. 5-9
THE USE OF PEDIATRIC CHEMOTHERAPY PROTOCOLS AT FULL DOSE IS BOTH A RATIONAL AND FEASIBLE TREATMENT STRATEGY IN ADULTS WITH EWINGS FAMILY TUMORS
Authors: VERRILL MW JUDSON IR WILTSHAW E THOMAS JM HARMER CL FISHER C
Citation: Mw. Verrill et al., THE USE OF PEDIATRIC CHEMOTHERAPY PROTOCOLS AT FULL DOSE IS BOTH A RATIONAL AND FEASIBLE TREATMENT STRATEGY IN ADULTS WITH EWINGS FAMILY TUMORS, Annals of oncology, 8(11), 1997, pp. 1099-1105
PHARMACOLOGICAL DISPOSITION OF A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE IN MICE
Authors: ORR RM RAYNAUD FI GODDARD PM JUDSON IR BECK T BRYAN B COTTER FE
Citation: Rm. Orr et al., PHARMACOLOGICAL DISPOSITION OF A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE IN MICE, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1699-1702
OLIGONUCLEOTIDE PHARMACOLOGY AND FORMULATION - G3139 ANTI-BCL2 PHOSPHOROTHIOATE IN STEALTH(R) LIPOSOMES AND GEL IMPLANTS
Authors: WOODLE MC RAYNAUD FI DIZIK M MEYER O HUANG SK JAEGER JA BROWN BD ORR R JUDSON IR PAPAHADJOPOULOS D
Citation: Mc. Woodle et al., OLIGONUCLEOTIDE PHARMACOLOGY AND FORMULATION - G3139 ANTI-BCL2 PHOSPHOROTHIOATE IN STEALTH(R) LIPOSOMES AND GEL IMPLANTS, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1731-1734
EWINGS-SARCOMA AND PRIMITIVE NEUROECTODERMAL TUMOR IN ADULTS - ARE THEY DIFFERENT FROM EWINGS-SARCOMA AND PRIMITIVE NEUROECTODERMAL TUMOR IN CHILDREN
Authors: VERRILL MW JUDSON IR HARMER CL FISHER C THOMAS JM WILTSHAW E
Citation: Mw. Verrill et al., EWINGS-SARCOMA AND PRIMITIVE NEUROECTODERMAL TUMOR IN ADULTS - ARE THEY DIFFERENT FROM EWINGS-SARCOMA AND PRIMITIVE NEUROECTODERMAL TUMOR IN CHILDREN, Journal of clinical oncology, 15(7), 1997, pp. 2611-2621
PHASE-I AND PHARMACOKINETIC STUDY OF AN ORAL PLATINUM COMPLEX GIVEN DAILY FOR 5 DAYS IN PATIENTS WITH CANCER
Authors: MCKEAGE MJ RAYNAUD F WARD J BERRY C ODELL D KELLAND LR MURRER B SANTABARABARA P HARRAP KR JUDSON IR
Citation: Mj. Mckeage et al., PHASE-I AND PHARMACOKINETIC STUDY OF AN ORAL PLATINUM COMPLEX GIVEN DAILY FOR 5 DAYS IN PATIENTS WITH CANCER, Journal of clinical oncology, 15(7), 1997, pp. 2691-2700
PHARMACOKINETICS OF G3139, A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE ANTISENSE TO BCL-2, AFTER INTRAVENOUS ADMINISTRATION OR CONTINUOUS SUBCUTANEOUS INFUSION TO MICE
Authors: RAYNAUD FI ORR RM GODDARD PM LACEY HA LANCASHIRE H JUDSON IR BECK T BRYAN B COTTER FE
Citation: Fi. Raynaud et al., PHARMACOKINETICS OF G3139, A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE ANTISENSE TO BCL-2, AFTER INTRAVENOUS ADMINISTRATION OR CONTINUOUS SUBCUTANEOUS INFUSION TO MICE, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 420-427
ANTITUMOR EFFECT OF TRIMELAMOL AGAINST HUMAN BREAST-CARCINOMA XENOGRAFTS IN NUDE-MICE
Authors: YAMADA Y KUBOTA T HOSHIYA Y ASANUMA F KOH JI KITAJIMA M COLEY HM JUDSON IR
Citation: Y. Yamada et al., ANTITUMOR EFFECT OF TRIMELAMOL AGAINST HUMAN BREAST-CARCINOMA XENOGRAFTS IN NUDE-MICE, Oncology Reports, 3(4), 1996, pp. 613-617
PHASE-I TRIAL OF ZDI694, A NEW FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITOR, IN PATIENTS WITH SOLID TUMORS
Authors: CLARKE SJ HANWELL J DEBEER M PLANTING A VERWEIJ J WALKER M SMITH R JACKMAN AL HUGHES LR HARRAP KR KENNEALEY GT JUDSON IR
Citation: Sj. Clarke et al., PHASE-I TRIAL OF ZDI694, A NEW FOLATE-BASED THYMIDYLATE SYNTHASE INHIBITOR, IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 14(5), 1996, pp. 1495-1503
THE ACTIVITY OF N-(HYDROXYMETHYL) MELAMINES IN FRESH HUMAN OVARIAN TUMOR-CELLS AND XENOGRAFTS
Authors: COLEY HM JARMAN M JONES M SARGENT JM KUBOTA T LEE NCJ GODDARD PM ELGIE AW WILLIAMSON C TAYLOR CG JUDSON IR
Citation: Hm. Coley et al., THE ACTIVITY OF N-(HYDROXYMETHYL) MELAMINES IN FRESH HUMAN OVARIAN TUMOR-CELLS AND XENOGRAFTS, Anticancer research, 16(4A), 1996, pp. 1851-1855
PRECLINICAL DEVELOPMENT OF THE ANTITUMOR AGENT CB-7646, BIS N-(HYDROXYMETHYL) TRIMETHYLMELAMINE, A STABLE ANALOG OF TRIMELAMOL
Authors: COLEY HM JARMAN M BROOKS N KUBOTA T GODDARD PM JONES M LEE N OWENS MD HALBERT GW JUDSON IR
Citation: Hm. Coley et al., PRECLINICAL DEVELOPMENT OF THE ANTITUMOR AGENT CB-7646, BIS N-(HYDROXYMETHYL) TRIMETHYLMELAMINE, A STABLE ANALOG OF TRIMELAMOL, International journal of cancer, 68(3), 1996, pp. 356-363
SURGICAL-TREATMENT OF LUNG METASTASES - THE EUROPEAN ORGANIZATION FORRESEARCH AND TREATMENT OF CANCER-SOFT TISSUE AND BONE SARCOMA GROUP-STUDY OF 255 PATIENTS
Authors: VANGEEL AN PASTORINO U JAUCH KW JUDSON IR VANCOEVORDEN F BUESA JM NIELSEN OS BOUDINET A TURSZ T SCHMITZ PIM
Citation: An. Vangeel et al., SURGICAL-TREATMENT OF LUNG METASTASES - THE EUROPEAN ORGANIZATION FORRESEARCH AND TREATMENT OF CANCER-SOFT TISSUE AND BONE SARCOMA GROUP-STUDY OF 255 PATIENTS, Cancer, 77(4), 1996, pp. 675-682
USE OF HIGH-DOSE CHEMOTHERAPY IN ADULT EWINGS-SARCOMA AND PNET
Authors: VERRILL MW JUDSON IR
Citation: Mw. Verrill et Ir. Judson, USE OF HIGH-DOSE CHEMOTHERAPY IN ADULT EWINGS-SARCOMA AND PNET, British Journal of Cancer, 73(8), 1996, pp. 28-28
ADULT EWINGS-SARCOMA - THE ROYAL-MARSDEN EXPERIENCE
Authors: VERRILL MW PREDOLAC D HILL CAL THOMAS JM HARMER CL MOSCOVIC EC FISHER C JUDSON IR
Citation: Mw. Verrill et al., ADULT EWINGS-SARCOMA - THE ROYAL-MARSDEN EXPERIENCE, European journal of cancer, 31A, 1995, pp. 1199-1199
PHARMACOKINETIC MODELING - A PRELUDE TO THERAPEUTIC DRUG-MONITORING FOR ALL CANCER-PATIENTS
Authors: JUDSON IR
Citation: Ir. Judson, PHARMACOKINETIC MODELING - A PRELUDE TO THERAPEUTIC DRUG-MONITORING FOR ALL CANCER-PATIENTS, European journal of cancer, 31A(11), 1995, pp. 1733-1735
PHARMACOKINETICS OF THE C-13 LABELED ANTICANCER AGENT TEMOZOLOMIDE DETECTED IN-VIVO BY SELECTIVE CROSS-POLARIZATION TRANSFER
Authors: ARTEMOV D BHUJWALLA ZM MAXWELL RJ GRIFFITHS JR JUDSON IR LEACH MO GLICKSON JD
Citation: D. Artemov et al., PHARMACOKINETICS OF THE C-13 LABELED ANTICANCER AGENT TEMOZOLOMIDE DETECTED IN-VIVO BY SELECTIVE CROSS-POLARIZATION TRANSFER, Magnetic resonance in medicine, 34(3), 1995, pp. 338-342
A PHASE-I AND PHARMACOLOGY STUDY OF AN ORAL PLATINUM COMPLEX, JM216 -DOSE-DEPENDENT PHARMACOKINETICS WITH SINGLE-DOSE ADMINISTRATION
Authors: MCKEAGE MJ MISTRY P WARD J BOXALL FE LOH S ONEILL C ELLIS P KELLAND LR MORGAN SE MURRER B SANTABARBARA P HARRAP KR JUDSON IR
Citation: Mj. Mckeage et al., A PHASE-I AND PHARMACOLOGY STUDY OF AN ORAL PLATINUM COMPLEX, JM216 -DOSE-DEPENDENT PHARMACOKINETICS WITH SINGLE-DOSE ADMINISTRATION, Cancer chemotherapy and pharmacology, 36(6), 1995, pp. 451-458
IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF BENZYL ISOTHIOCYANATE - A NATURAL PRODUCT FROM TROPAEOLUM-MAJUS
Authors: PINTAO AM PAIS MSS COLEY H KELLAND LR JUDSON IR
Citation: Am. Pintao et al., IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF BENZYL ISOTHIOCYANATE - A NATURAL PRODUCT FROM TROPAEOLUM-MAJUS, Planta medica, 61(3), 1995, pp. 233-236
IDOXIFENE - REPORT OF A PHASE-I STUDY IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: COOMBES RC HAYNES BP DOWSETT M QUIGLEY M ENGLISH J JUDSON IR GRIGGS LJ POTTER GA MCCAGUE R JARMAN M
Citation: Rc. Coombes et al., IDOXIFENE - REPORT OF A PHASE-I STUDY IN PATIENTS WITH METASTATIC BREAST-CANCER, Cancer research, 55(5), 1995, pp. 1070-1074
THE ROLE OF THE N-(HYDROXYMETHYL)MELAMINES AS ANTITUMOR AGENTS - MECHANISM OF ACTION STUDIES
Authors: COLEY HM BROOKS N PHILLIPS DH HEWER A JENKINS TC JARMAN M JUDSON IR
Citation: Hm. Coley et al., THE ROLE OF THE N-(HYDROXYMETHYL)MELAMINES AS ANTITUMOR AGENTS - MECHANISM OF ACTION STUDIES, Biochemical pharmacology, 49(9), 1995, pp. 1203-1212
STABLE ANALOGS OF THE ANTITUMOR AGENT TRIMELAMOL RETAIN IN-VITRO CYTOTOXICITY IN DRUG-SENSITIVE AND RESISTANT RODENT AND HUMAN CELL-LINES
Authors: COLEY HM JARMAN M BROOKS N THORNTON TJ JUDSON IR
Citation: Hm. Coley et al., STABLE ANALOGS OF THE ANTITUMOR AGENT TRIMELAMOL RETAIN IN-VITRO CYTOTOXICITY IN DRUG-SENSITIVE AND RESISTANT RODENT AND HUMAN CELL-LINES, European journal of cancer, 30A(12), 1994, pp. 1827-1836
Risultati: 1-25 | 26-29